Amgen Inc., adjusted current assets

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Current assets	30,332)	22,186)	19,385)	21,144)	18,440)
Adjustments
Add: Allowance for doubtful accounts	28)	22)	26)	32)	26)
After Adjustment
Adjusted current assets	30,360)	22,208)	19,411)	21,176)	18,466)

Download chart

Amgen Inc., adjusted total assets

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Total assets	97,154)	65,121)	61,165)	62,948)	59,707)
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Add: Allowance for doubtful accounts	28)	22)	26)	32)	26)
After Adjustment
Adjusted total assets	97,182)	65,143)	61,191)	62,980)	59,733)

¹ Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

Download chart

Amgen Inc., adjusted total liabilities

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Total liabilities	90,922)	61,460)	54,465)	53,539)	50,034)
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Less: Long-term deferred tax liabilities²	2,354)	11)	—)	—)	—)
After Adjustment
Adjusted total liabilities	88,568)	61,449)	54,465)	53,539)	50,034)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Long-term deferred tax liabilities. See details »

Download chart

Amgen Inc., adjusted stockholders’ equity

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Stockholders’ equity	6,232)	3,661)	6,700)	9,409)	9,673)
Adjustments
Less: Deferred income taxes, net¹	446)	943)	219)	(201)	(514)
Add: Allowance for doubtful accounts	28)	22)	26)	32)	26)
After Adjustment
Adjusted stockholders’ equity	5,814)	2,740)	6,507)	9,642)	10,213)

¹ Deferred income taxes, net. See details »

Download chart

Amgen Inc., adjusted capitalization table

US$ in millions

	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Current portion of long-term debt	1,443)	1,591)	87)	91)	2,953)
Long-term debt, excluding current portion	63,170)	37,354)	33,222)	32,895)	26,950)
Total reported debt	64,613)	38,945)	33,309)	32,986)	29,903)
Stockholders’ equity	6,232)	3,661)	6,700)	9,409)	9,673)
Total reported capital	70,845)	42,606)	40,009)	42,395)	39,576)
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)¹	—)	—)	—)	—)	—)
Add: Current operating lease liabilities (included in Accrued liabilities)²	119)	156)	145)	153)	140)
Add: Noncurrent operating lease liabilities (included in Other noncurrent liabilities)³	691)	539)	525)	306)	388)
Adjusted total debt	65,423)	39,640)	33,979)	33,445)	30,431)
Adjustments to Equity
Less: Deferred income taxes, net⁴	446)	943)	219)	(201)	(514)
Add: Allowance for doubtful accounts	28)	22)	26)	32)	26)
Adjusted stockholders’ equity	5,814)	2,740)	6,507)	9,642)	10,213)
After Adjustment
Adjusted total capital	71,237)	42,380)	40,486)	43,087)	40,644)

¹ Operating lease liability (before adoption of FASB Topic 842). See details »

² Current operating lease liabilities (included in Accrued liabilities). See details »

³ Noncurrent operating lease liabilities (included in Other noncurrent liabilities). See details »

⁴ Deferred income taxes, net. See details »

Download chart

Amgen Inc., adjusted net income

US$ in millions

12 months ended:	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
As Reported
Net income	6,717)	6,552)	5,893)	7,264)	7,842)
Adjustments
Add: Deferred income tax expense (benefit)¹	(1,215)	(1,275)	(434)	(363)	(304)
Add: Increase (decrease) in allowance for doubtful accounts	6)	(4)	(6)	6)	(22)
Add: Other comprehensive income (loss), net of taxes	(58)	565)	189)	(457)	241)
After Adjustment
Adjusted net income	5,450)	5,838)	5,642)	6,450)	7,757)

¹ Deferred income tax expense (benefit). See details »

Download chart

Amgen Inc. (NASDAQ:AMGN)

Adjustments to Financial Statements